EMA — authorised 27 October 2011
- Marketing authorisation holder: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A
- Status: approved
EMA authorised Alaxin on 27 October 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 27 October 2011.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A holds the EU marketing authorisation.